Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Group cognitive–behavioural therapy for schizophrenia : randomised controlled trial.
AU - Barrowclough, Christine
AU - Haddock, Gillian
AU - Lobban, Fiona
AU - Jones, Steven H.
AU - Siddle, Ron
AU - Roberts, Chris
AU - Gregg, Lynsey
PY - 2006/12
Y1 - 2006/12
N2 - Background The efficacy of cognitive–behavioural therapy for schizophrenia is established, butthere is less evidence for a group format. Aims To evaluate the effectiveness of group cognitive–behavioural therapy for schizophrenia. Method In all, 113 people with persistent positive symptoms of schizophrenia were assigned to receive group cognitive–behavioural therapy or treatment as usual. The primary outcome was positive symptom improvement on the Positive and Negative Syndrome Scales. Secondary outcome measures included symptoms, functioning, relapses, hopelessness and self-esteem. Results There were no significant differences between the cognitive–behavioural therapy and treatment as usual on measures of symptoms or functioning or relapse, but group cognitive–behavioural therapy treatment resulted in reductions in feelings of hopelessness and in low self-esteem. Conclusions Although group cognitive–behavioural therapy may not be the optimum treatment method for reducing hallucinations and delusions, it may have important benefits, including feeling less negative about oneself and less hopeless for the future.
AB - Background The efficacy of cognitive–behavioural therapy for schizophrenia is established, butthere is less evidence for a group format. Aims To evaluate the effectiveness of group cognitive–behavioural therapy for schizophrenia. Method In all, 113 people with persistent positive symptoms of schizophrenia were assigned to receive group cognitive–behavioural therapy or treatment as usual. The primary outcome was positive symptom improvement on the Positive and Negative Syndrome Scales. Secondary outcome measures included symptoms, functioning, relapses, hopelessness and self-esteem. Results There were no significant differences between the cognitive–behavioural therapy and treatment as usual on measures of symptoms or functioning or relapse, but group cognitive–behavioural therapy treatment resulted in reductions in feelings of hopelessness and in low self-esteem. Conclusions Although group cognitive–behavioural therapy may not be the optimum treatment method for reducing hallucinations and delusions, it may have important benefits, including feeling less negative about oneself and less hopeless for the future.
U2 - 10.1192/bjp.bp.106.021386
DO - 10.1192/bjp.bp.106.021386
M3 - Journal article
VL - 189
SP - 527
EP - 532
JO - British Journal of Psychiatry
JF - British Journal of Psychiatry
SN - 1472-1465
IS - 6
ER -